| Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis | International journal of molecular sciences |  | | 2022 | 276 | 189 |
|
| Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack | Cell Reports. Medicine | | | 2021 | 246 | 260 |
|
| Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study | BMC Infectious Diseases | | | 2018 | 547 | 319 |
|
| Replicating viral vector platform exploits alarmin signals for potent CD8(+) T cell-mediated tumour immunotherapy | Nature Communications | | | 2017 | 660 | 328 |
|
| La nucléoprotéine est nécessaire à l'immunogénicité des vecteurs vaccinaux basés sur les virus de la chorioméningite lymphocytaire recombinants (rLCMV) | | | | 2016 | 666 | 250 |
|
| The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector Immunogenicity | Journal of virology |  | | 2015 | 607 | 2 |
|
| Developmental and metabolic brain alterations in rats exposed to bisphenol A during gestation and lactation | International journal of developmental neuroscience | | | 2011 | 673 | 2 |
|
